Eloxx Pharmaceuticals, Inc.
ELOX
$18.76
-$0.31-1.63%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
8/12/2026
-
Nasdaq News: Markets
8/12/2026
-
PR Newswire
8/11/2026
-
The Cerbat Gem
8/11/2026
-
SeekingAlpha.com: All News
8/7/2026
-
The Cerbat Gem
8/3/2026
-
The Cerbat Gem
7/22/2026
-
TipRanks: TheFly
7/20/2026
-
TipRanks: TheFly
7/20/2026
-
TipRanks: TheFly
7/19/2026
-
The Cerbat Gem
7/9/2026
-
TipRanks: TheFly
7/9/2026
-
TipRanks: TheFly
7/1/2026
-
TipRanks
6/16/2026
-
TipRanks: TheFly
6/16/2026
-
TipRanks: TheFly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Tuesday, May 5, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of May 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
781 577 5300
Address
P.O. Box 274
Arlington, MA 02476
Arlington, MA 02476
Country
Year Founded
Business Description
Sector
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates that modulate the ribosome and promote readthrough of premature stop codons...
more